markdownabstractBackground: Intratumor heterogeneity has been demonstrated in several cancer types, following a model of branched evolution. It is unknown to which extent intratumor heterogeneity is applicable to esophageal adenocarcinoma. Therefore the aim of this study was to characterise intratumor heterogeneity in esophageal adenocarcinoma. Methods: Multiregional targeted sequencing of four commonly altered genes was performed on 19 tumor regions collected from five esophageal adenocarcinomas. Alterations were classified as homogeneous or heterogeneous based on mutational and loss of heterozygosity analysis. Results: Identical TP53 mutations and homogeneously loss of heterozygosity of the TP53 locus were identified in all separate...
Simple Summary Cancer of the esophagus is a deadly disease. There are two main subtypes, adenocarcin...
Esophageal squamous cell carcinoma (ESCC) is among the most common malignancies, but little is known...
Esophageal adenocarcinoma (EAC) has a poor outcome, and targeted therapy trials have thus far been d...
Abstract Background Intratumor heterogeneity has been demonstrated in several cancer types, followin...
INTRODUCTION: Our study aimed at investigating tumor heterogeneity in esophageal adenocarcinoma (E...
Mixed adenoneuroendocrine carcinoma (MANEC) in the esophagus is an infrequent but highly malignant c...
Cancer is a disease of genome instability and genomic alterations; now, genomic heterogeneity is rap...
Cancer is a disease of genome instability and genomic alterations; now, genomic heterogeneity is rap...
Cancer is a disease of genome instability and genomic alterations; now, genomic heterogeneity is rap...
Abstract: Simple Summary The molecular heterogeneity of esophageal adenocarcinoma (EAC), a severe ma...
INTRODUCTION: Our study aimed at investigating tumor heterogeneity in esophageal adenocarcinoma ...
INTRODUCTION: Our study aimed at investigating tumor heterogeneity in esophageal adenocarcinoma ...
The molecular genetic relationship between esophageal adenocarcinoma (EAC) and its precursor lesion,...
Esophageal squamous cell carcinoma (ESCC) is among the most common malignancies, but little is known...
Abstract Background Cancer is a somatic evolutionary disease and adenocarcinomas of the stomach and ...
Simple Summary Cancer of the esophagus is a deadly disease. There are two main subtypes, adenocarcin...
Esophageal squamous cell carcinoma (ESCC) is among the most common malignancies, but little is known...
Esophageal adenocarcinoma (EAC) has a poor outcome, and targeted therapy trials have thus far been d...
Abstract Background Intratumor heterogeneity has been demonstrated in several cancer types, followin...
INTRODUCTION: Our study aimed at investigating tumor heterogeneity in esophageal adenocarcinoma (E...
Mixed adenoneuroendocrine carcinoma (MANEC) in the esophagus is an infrequent but highly malignant c...
Cancer is a disease of genome instability and genomic alterations; now, genomic heterogeneity is rap...
Cancer is a disease of genome instability and genomic alterations; now, genomic heterogeneity is rap...
Cancer is a disease of genome instability and genomic alterations; now, genomic heterogeneity is rap...
Abstract: Simple Summary The molecular heterogeneity of esophageal adenocarcinoma (EAC), a severe ma...
INTRODUCTION: Our study aimed at investigating tumor heterogeneity in esophageal adenocarcinoma ...
INTRODUCTION: Our study aimed at investigating tumor heterogeneity in esophageal adenocarcinoma ...
The molecular genetic relationship between esophageal adenocarcinoma (EAC) and its precursor lesion,...
Esophageal squamous cell carcinoma (ESCC) is among the most common malignancies, but little is known...
Abstract Background Cancer is a somatic evolutionary disease and adenocarcinomas of the stomach and ...
Simple Summary Cancer of the esophagus is a deadly disease. There are two main subtypes, adenocarcin...
Esophageal squamous cell carcinoma (ESCC) is among the most common malignancies, but little is known...
Esophageal adenocarcinoma (EAC) has a poor outcome, and targeted therapy trials have thus far been d...